DK1240310T3 - Fremgangsmåde til inaktivering af mikroorganismer - Google Patents

Fremgangsmåde til inaktivering af mikroorganismer

Info

Publication number
DK1240310T3
DK1240310T3 DK00993526T DK00993526T DK1240310T3 DK 1240310 T3 DK1240310 T3 DK 1240310T3 DK 00993526 T DK00993526 T DK 00993526T DK 00993526 T DK00993526 T DK 00993526T DK 1240310 T3 DK1240310 T3 DK 1240310T3
Authority
DK
Denmark
Prior art keywords
microorganism
inactivant
cross
linking agent
inactivating microorganisms
Prior art date
Application number
DK00993526T
Other languages
Danish (da)
English (en)
Inventor
Simon Johannes Barteling
Original Assignee
Agricultural Research Council
Inst Animal Science And Health
Simon Johannes Barteling
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agricultural Research Council, Inst Animal Science And Health, Simon Johannes Barteling filed Critical Agricultural Research Council
Application granted granted Critical
Publication of DK1240310T3 publication Critical patent/DK1240310T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/135—Foot- and mouth-disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32161—Methods of inactivation or attenuation
    • C12N2770/32163—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Fertilizers (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK00993526T 1999-12-20 2000-12-18 Fremgangsmåde til inaktivering af mikroorganismer DK1240310T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA997757 1999-12-20
PCT/ZA2000/000254 WO2001046390A2 (en) 1999-12-20 2000-12-18 Method of inactivating microorganisms

Publications (1)

Publication Number Publication Date
DK1240310T3 true DK1240310T3 (da) 2008-05-26

Family

ID=25588046

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00993526T DK1240310T3 (da) 1999-12-20 2000-12-18 Fremgangsmåde til inaktivering af mikroorganismer

Country Status (14)

Country Link
US (1) US6673349B2 (de)
EP (1) EP1240310B1 (de)
JP (1) JP2003517834A (de)
AT (1) ATE384786T1 (de)
AU (1) AU782907B2 (de)
BR (1) BR0016563A (de)
CA (1) CA2394946C (de)
CY (1) CY1107420T1 (de)
DE (1) DE60037907T2 (de)
DK (1) DK1240310T3 (de)
ES (1) ES2300286T3 (de)
PT (1) PT1240310E (de)
TR (1) TR200202104T2 (de)
WO (1) WO2001046390A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE526034T1 (de) * 2004-01-21 2011-10-15 Merial Ltd Verbesserte inaktivierte fcv-vakzinen
WO2010071237A1 (ja) * 2008-12-19 2010-06-24 株式会社さいわいメディックス タンパク質架橋固定試薬で固定した微生物を抗原として用いる網羅的抗表面抗体作製法
WO2010144797A2 (en) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Influenza vaccines with enhanced immunogenicity and uses thereof
CN102406931B (zh) * 2011-11-25 2014-02-05 成都康华生物制品有限公司 大流行流感病毒裂解疫苗
CN105056225B (zh) * 2015-07-30 2018-01-16 成都天邦生物制品有限公司 一种灭活疫苗的制备方法
CA3010049C (en) * 2016-01-15 2021-10-12 The Chemo-Sero-Therapeutic Research Institute Vaccine containing immobilized virus particles
CN114540317A (zh) * 2022-03-17 2022-05-27 新疆方牧生物科技有限公司 一种悬浮培养口蹄病毒灭活的工艺方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1924303A1 (de) 1969-05-13 1970-12-17 Bayer Ag AEthylaethylenimin als Inaktivierungsmittel
US5069901A (en) * 1988-02-03 1991-12-03 Jones Elaine V Preparation of a recombinant subunit vaccine against pseudorabies infection
US5242686A (en) 1990-11-07 1993-09-07 American Home Products Corporation Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
GB9110808D0 (en) * 1991-05-17 1991-07-10 Retroscreen Ltd Aids vaccine and method for its production
ATE197314T1 (de) * 1993-02-08 2000-11-15 Bayer Ag Verfahren zum vermehren des das reproduktions- und atemwegs-syndrom verursachenden schweinevirus und dessen verwendung als impfstoff.
TR199801336T2 (xx) * 1996-02-23 1998-10-21 The Procter & Gamble Company Dezenfekte edici bile�imler.

Also Published As

Publication number Publication date
JP2003517834A (ja) 2003-06-03
EP1240310A2 (de) 2002-09-18
WO2001046390A3 (en) 2001-12-20
PT1240310E (pt) 2008-05-05
AU2979601A (en) 2001-07-03
WO2001046390A2 (en) 2001-06-28
US20030035811A1 (en) 2003-02-20
DE60037907D1 (de) 2008-03-13
AU782907B2 (en) 2005-09-08
DE60037907T2 (de) 2009-07-09
CA2394946C (en) 2010-12-14
BR0016563A (pt) 2002-09-10
TR200202104T2 (tr) 2002-12-23
US6673349B2 (en) 2004-01-06
EP1240310B1 (de) 2008-01-23
CA2394946A1 (en) 2001-06-28
ES2300286T3 (es) 2008-06-16
ATE384786T1 (de) 2008-02-15
CY1107420T1 (el) 2012-12-19

Similar Documents

Publication Publication Date Title
CY1107420T1 (el) Μεθοδος απενεργοποιησεως μικροοργανισμων
AR055422A2 (es) Composicion de antigeno, composicion de vacuna y procedimiento para tratar un cerdo
ATE396739T1 (de) Entwicklung einer vakzine zur prävention von infektionen mit filovirus bei primaten
ATE279469T1 (de) Thermisch härtbare, wässrige zusammensetzungen
DE602004020189D1 (de) Adjuvante influenza-vakzine
PT865297E (pt) Composicoes de vacinas para administracao intranasal compreendendo quitosano e suas utilizacoes
EA199900069A1 (ru) Вакцинная композиция против малярии
DK0915648T3 (da) Fremgangsmåder og præparater til selektiv modificering af nukleinsyrer
DE69841676D1 (de) Verfahren zur extraktion und isolierung von bakteriellen hüllpolysacchariden zur verwendung als vakzine oder, an proteine gekoppelt, als konjugierte vakzine
DE60226175D1 (de) Mycobakterieller impfstoff
DK0550450T3 (da) Anvendelse af tværbundne krystaller som ny fremgangsmåde til immobilisering af enzymer
ATE507286T1 (de) Immunisierung von fischen gegen virusinfektion
EP1395283A4 (de) Heterologer schutz, induziert durch immunisierung mit der invaplex-vakzine
AR021948A1 (es) Metodo para preparar una vacuna inactivada, adyuvada con una emulsion a/a y kit de partes
ATE456958T1 (de) Mannose als adjuvant für intranasale vakzine
ATE213646T1 (de) Grippe-impfstoff
DE69912652D1 (de) Verfahren zur herstellung von citalopram
NL300336I1 (nl) Vaccin tegen de bof dat een jeryl-lynn virusstam bevat
NO20020615D0 (no) Vaksine
DE59610629D1 (de) Immunogenes konstrukt, verfahren zu dessen herstellung und verwendung als vakzine
PT757556E (pt) Bacterina borrelia burgdorferi
ATE343390T1 (de) Kalzilytische verbindungen
ATE251121T1 (de) Verfahren zur herstellung von 1,3,6- hexantricarbonitril
AR027030A1 (es) Metodo para la inactivacion de microorganismos
WO2003054176A3 (en) Preparation of vaccines using photosensitizer and light